Status:
COMPLETED
Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
Mukoviszidose eV Bonn Germany
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6+ years
Brief Summary
Staphylococcus aureus is not only one of the first pathogens infecting the airways of cystic fibrosis (CF) patients, but also a highly prevalent microorganism (\>60% of all CF patients; European and A...
Detailed Description
Protocol synopsis Title: Dissection of Staphylococcus aureus infection from colonization in cystic fibrosis patients. A non-interventional prospective, 2-year longitudinal multicenter study Study obj...
Eligibility Criteria
Inclusion
- positive S. aureus cultures for more than 6 months within the last year; children (\>6 years) and patients with CF, who are able to perform lung function tests
Exclusion
- Pseudomonas aeruginosa and/or Burkholderia cepacia colonization or infection for more than 6 months within the last year before recruitment; patients who have not been colonized with these pathogens before but acquire them within the study period and are colonized/infected for more than 6 months during the observation period
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT00669760
Start Date
July 1 2008
End Date
January 1 2015
Last Update
January 7 2015
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Universität Innsbruck
Innsbruck, Austria, 6020
2
Charite Berlin Campus Benjamin Franklin
Berlin, Germany, 12200
3
Clinic for Children and Adolescents Ruhr University Bochum St Josef Hospital
Bochum, Germany, 44791
4
Universitätsklinikum Carl Gustav Carus
Dresden, Germany, 01307